chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 28-DEC-2022, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
Age: 11.0
Sex: F
Vaccine: HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9, HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 14-MAR-2023, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several cases received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Nervous system disorder, Vaccination failure
Clinical narrative: the shingle shot caused me to get them/suspected vaccination failure; the shingle shot caused me to get them; nerve ending that are weak; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: the shingle shot caused me to get them/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: the shingle shot caused me to get them) and nervous system disorder (Verbatim: nerve ending that are weak). The outcome of the vaccination failure was unknown and the outcome of the shingles and nervous system disorder were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and nervous system disorder to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles and nervous system disorder to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by patient via interactive digital media. The reporter stated that shingles shot caused him/her to get shingles.  The patient mentioned that if you had nerve ending that were weak that would happen, but they would not tell you that.  This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow up was not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; got shingles.; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got shingles.). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient got shingles a year after he/she got the shingles vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. The case had been linked to US2023AMR066806, reported by the same reporter , for a different patient.; Sender's Comments:  US-GSK-US2023AMR066806:same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had the vaccine but still got shingles/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the vaccine but still got shingles/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 31-MAR-2023 This case was reported by patient's relative via  interactive digital media. The reporter reported that his or her mother received Shingles vaccine and experienced shingles right now. The reporter also reported that it had been 3 weeks and shingles are just started to heal. The reporter reported that it was the worst thing ever she had. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting. The follow-up could not be possible as the as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had it before, still gor the shingles/ Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had it before, still gor the shingles/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and still experienced shingles. The patient stated that no vaccine of any kind for him or her. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Ophthalmic herpes zoster, Vaccination failure
Clinical narrative: have the vaccine, still got shingles/ Suspected vaccination failure; Shingles in eye; Shingles on face and head; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: have the vaccine, still got shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: Shingles in eye) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles on face and head). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster and shingles were not reported.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and still experienced shingles on his or her face, head and eye. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had Vx, Got the shots and has had shingles/suspected vaccination failure; has had shingles 3 times since; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included shingles (patient's cousin had shingles 7 years ago) and nerve damage (patient's cousin left with permanent nerve damage).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had Vx, Got the shots and has had shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: has had shingles 3 times since). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's cousin via interactive digital media. The reporter had shingles 7 years ago and was left with permanent nerve damage and had been a struggle ever since.  It was a horrible virus but he/she did not sure how much the shingles vaccine would help.  The patient got the shingles shots and had shingles three times since.  The reporter sated that so it was just a personal choice whether to get it or not. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. The case had been linked to US2023AMR066981, reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2023AMR066981:Same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the shots and got shingles/suspected vaccination failure; Got light case, no lasting damage; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included shingles (patient's wife had shingles 7 years ago) and nerve damage (patient's wife had left with permanent nerve damage).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shots and got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got light case, no lasting damage). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's wife via interactive digital media. The patient got the shingles shots and he got a light case of shingles with no lasting damage. The reporter stated that so it was just a personal choice whether to get shingles vaccine or not.  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. The case had been linked to US2023AMR066976, reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2023AMR066976:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shot and still got shingles/suspected vaccination failure; Still got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shot and still got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Still got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the shingles vaccine and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got Vax and got shingles, does not work/suspected vaccination failure; Got shingles, really bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got Vax and got shingles, does not work/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles, really bad). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's relative via interactive digital media. The patient got the shingles vaccine and got shingles. The reporter stated that it was really bad and the shingles vaccine did not work. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR067014:Same reporter US-GSK-US2023AMR067015:Same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got Vax and got shingles, does not work/suspected vaccination failure; Got shingles, really bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got Vax and got shingles, does not work/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles, really bad). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's relative via interactive digital media. The reporter reported that the patient received shingles vaccine and still experienced shingles really bad. The reporter stated that the vaccine does not work. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available. This case had been linked with US2023AMR067015 and US2023AMR067010 by same reporter for different patient.; Sender's Comments:  US-GSK-US2023AMR067010:Same reporter US-GSK-US2023AMR067015:Same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got Vax and got shingles, does not work/ suspected vaccination failure; Got shingles, really bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got Vax and got shingles, does not work/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles, really bad). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's relative via interactive digital media. The reporter reported that the patient received shingles vaccine and still experienced shingles really bad. The reporter stated that the vaccine does not work. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available. This case had been linked with US2023AMR067014 and US2023AMR067010 by same reporter for different patient.; Sender's Comments:  US-GSK-US2023AMR067014:Same reporter US-GSK-US2023AMR067010:Same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Death, Herpes zoster, Immunodeficiency, Platelet count decreased, Transfusion
Clinical narrative: he passed 2 months later; Shingles Vax gave my husband Shingles; compromised immune system; Shingles Vax gave my husband Shingles; wiped out his platelets; This serious case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced unknown cause of death (Verbatim: he passed 2 months later) (serious criteria death and GSK medically significant), vaccination failure (Verbatim: Shingles Vax gave my husband Shingles) (serious criteria GSK medically significant), immunocompromised (Verbatim: compromised immune system) (serious criteria GSK medically significant), shingles (Verbatim: Shingles Vax gave my husband Shingles) and platelets decreased (Verbatim: wiped out his platelets). The patient was treated with blood transfusion, auxiliary products (Blood Transfusion). The outcome of the vaccination failure was unknown and the outcome of the immunocompromised, shingles and platelets decreased were not reported. The reported cause of death was unknown.   It was unknown if the reporter considered the unknown cause of death, vaccination failure, immunocompromised, shingles and platelets decreased to be related to Shingles vaccine.     It was unknown if the company considered the unknown cause of death, vaccination failure, immunocompromised, shingles and platelets decreased to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023. This case was reported by a patient via interactive digital media. The reporter stated that shingles vaccination gave her husband Shingles, wiped out his platelets. The patient required 4 blood transfusions and with his compromised immune system he passed 2 months later. The case was considered as suspected vacciantion failure since the details regarding completion of primary vaccination failure, time to onset for shingles laboratory confirmation of shingles was not reported.  The follow-up could not be possible as no contact details were available; Reported Cause(s) of Death: Unknown cause of death
Sex: M
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: he passed 2 months later; Shingles Vax gave my husband Shingles; compromised immune system; Shingles Vax gave my husband Shingles; wiped out his platelets; This serious case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced unknown cause of death (Verbatim: he passed 2 months later) (serious criteria death and GSK medically significant), vaccination failure (Verbatim: Shingles Vax gave my husband Shingles) (serious criteria GSK medically significant), immunocompromised (Verbatim: compromised immune system) (serious criteria GSK medically significant), shingles (Verbatim: Shingles Vax gave my husband Shingles) and platelets decreased (Verbatim: wiped out his platelets). The patient was treated with blood transfusion, auxiliary products (Blood Transfusion). The outcome of the vaccination failure was unknown and the outcome of the immunocompromised, shingles and platelets decreased were not reported. The reported cause of death was unknown.   It was unknown if the reporter considered the unknown cause of death, vaccination failure, immunocompromised, shingles and platelets decreased to be related to Shingles vaccine.     It was unknown if the company considered the unknown cause of death, vaccination failure, immunocompromised, shingles and platelets decreased to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023. This case was reported by a patient via interactive digital media. The reporter stated that shingles vaccination gave her husband Shingles, wiped out his platelets. The patient required 4 blood transfusions and with his compromised immune system he passed 2 months later. The case was considered as suspected vacciantion failure since the details regarding completion of primary vaccination failure, time to onset for shingles laboratory confirmation of shingles was not reported.  The follow-up could not be possible as no contact details were available; Reported Cause(s) of Death: Unknown cause of death
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: weeks later he developed shingles/Suspected Vaccination Failure; weeks later he developed shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: weeks later he developed shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: weeks later he developed shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's friend via interactive digital media. The patient got the shingles jab on a recommendation from his doctor and weeks later he developed shingles.  The reporter certainly would not be getting this shingles jab either. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I recently had the shingles and was vaccinated/Suspected Vaccination Failure; I recently had the shingles and was vaccinated; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I recently had the shingles and was vaccinated/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: I recently had the shingles and was vaccinated). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient recently had the shingles and was vaccinated with shingles.  The patient wondered how that happened. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I had it twice before the vaccine and twice afterward/Suspected Vaccination Failure; I had it twice before the vaccine and twice afterward; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles twice before the shingles vaccination).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I had it twice before the vaccine and twice afterward/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: I had it twice before the vaccine and twice afterward). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the shingles four times. The patient had shingles twice afterward the shingles vaccination. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Near death experience
Clinical narrative: That vaccine almost killed me; This serious case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced near death experience (Verbatim: That vaccine almost killed me) (serious criteria GSK medically significant and life threatening). The outcome of the near death experience was not reported.  It was unknown if the reporter considered the near death experience to be related to Shingles vaccine.  It was unknown if the company considered the near death experience to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient did not get the second shot.  The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the poke and ended up getting shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the poke and ended up getting shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a consumer via interactive digital media. The patient got the poke (shingles vaccine) and ended up getting shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. This case had been linked to US2023AMR067344, reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2023AMR067344:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the poke and ended up getting shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the poke and ended up getting shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a consumer via interactive digital media. The patient got the poke (shingles vaccine) and ended up getting shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. The case had been linked to US2023AMR067341, reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2023AMR067341:Same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Paralysis
Clinical narrative: is paralysed; This serious case was reported by a consumer via interactive digital media and described the occurrence of paralysis in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced paralysis (Verbatim: is paralysed) (serious criteria GSK medically significant). The outcome of the paralysis was not reported.   It was unknown if the reporter considered the paralysis to be related to Shingles vaccine.   It was unknown if the company considered the paralysis to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's parent via interactive digital media. The reporter would never get this shingles vaccine. The reporter stated that adverse reactions were severe.  The patient was paralyzed and he/she blamed the shingles vaccine. The follow up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: My mom was vaccinated and has had shingles/ Suspected vaccination failure; Constant pain; Has had shingles for over 4mos; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: My mom was vaccinated and has had shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Has had shingles for over 4mos) and pain (Verbatim: Constant pain). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved (duration 4 months) and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by the patient via interactive digital media. The patient had stated that his/her mom was vaccinated and has had shingles for over 4 months with constant pain. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible, as no contact, details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: 2 vaccines one year ago and got shingles; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In MAR-2023, between 11 and 12 months after receiving Shingles vaccine and an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: 2 vaccines one year ago and got shingles) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023. The patient reported this case via interactive digital media. The patient had the 2 vaccines one year ago, and 5 days before, surprise the patient got shingles. Not bad, for at the time of reporting. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Gait inability, Guillain-Barre syndrome, Wheelchair user
Clinical narrative: Gillian-Barre Syndrome; unable to walk; currently in a wheelchair; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: Gillian-Barre Syndrome) (serious criteria GSK medically significant), unable to walk (Verbatim: unable to walk) and wheelchair user (Verbatim: currently in a wheelchair). The outcome of the guillain barre syndrome, unable to walk and wheelchair user were not reported.   It was unknown if the reporter considered the guillain barre syndrome, unable to walk and wheelchair user to be related to Shingles vaccine.     It was unknown if the company considered the guillain barre syndrome, unable to walk and wheelchair user to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023. The patient reported this case via interactive digital media. The reporter stated that friend of his/ her was currently in a wheelchair, unable to walk after her first dose of this vaccination. The patient developed Gillian-Barre Syndrome, a side effect.
Sex: U
Vaccine: VARZOS
Symptoms: Deafness
Clinical narrative: went deaf from the shingles vaccine/went deaf after getting the shingles shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of deafness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced deafness (Verbatim: went deaf from the shingles vaccine/went deaf after getting the shingles shot) (serious criteria GSK medically significant). The outcome of the deafness was not reported.   It was unknown if the reporter considered the deafness to be related to Shingles vaccine.     It was unknown if the company considered the deafness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023. The patient reported this case via interactive digital media. The reporter had a friend who went deaf after getting the shingles shot as a side effect. The reporter said to check the side effects they list before you do anything like this.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had the vaccine and still got it pretty bad/ Suspected vaccination failure; still got it pretty bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the vaccine and still got it pretty bad/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: still got it pretty bad). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that, he/she could not imagine what it would had been like without the vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.